BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Report

TITAN PHARMACEUTICALS INC

via THE LIVINGSTON GROUP, LLC

4th Quarter (Oct 1 - Dec 31) · 2020Posted Jan 14, 2021Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: TITAN PHARMACEUTICALS INC
Description: Pharmaceutical company
Location: California · United States of America

Registrant

Firm: THE LIVINGSTON GROUP, LLC
Description: Government and Public Relations consultants
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Coverage and recognition of opioid addiction treatment
LobbyistsROBERT L LIVINGSTON · J ALLEN MARTIN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

TITAN PHARMACEUTICALS INC — Lobbying — Receipts Report